Making cell-free DNA testing accessible to all healthcare providers
29

Press Release

Gene Solutions’ SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
Gene Solutions divider

Gene Solutions’ SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight

Key finding:

A blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and highlighted by the American Society of Clinical Oncology. For Gene Solutions, this milestone underscores the growing global relevance of Asia-led multi-cancer detection innovation.

Authors:

GENE SOLUTIONS SGP PTE. LTD.
Publisher:PR Newswire
Publication date:07 July 2026
This publication supports for the following genetic testing:
Gene Solutions Hosts K-CONNECT Summit 2026, Uniting Oncology Experts Across Asia-Pacific
Gene Solutions divider

Gene Solutions Hosts K-CONNECT Summit 2026, Uniting Oncology Experts Across Asia-Pacific

Key finding:

DA NANG, Vietnam, June 18, 2026 /PRNewswire/ — Gene Solutions announced the successful conclusion of K-CONNECT Summit 2026, a regional scientific forum that brought together leading oncology experts, clinicians, researchers and healthcare stakeholders to discuss how Artificial Intelligence (AI) and multi-omics are reshaping cancer care across Asia-Pacific.

Authors:

GENE SOLUTIONS SGP PTE. LTD.
Publisher:PR Newswire
Publication date:18 June 2026
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions’ SPOT-MAS 10 Multi-Cancer Screening Test
Gene Solutions divider

FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions’ SPOT-MAS 10 Multi-Cancer Screening Test

Key finding:

SINGAPORE, May 27, 2026 /PRNewswire/ — Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to SPOT-MAS 10, its multi-omic blood test designed to detect cancer-associated signals.

Authors:

GENE SOLUTIONS SGP PTE. LTD.
Publisher:PR Newswire
Publication date:28 May 2026
Advancing Precision Oncology in Taiwan
Gene Solutions divider

Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan

Key finding:

TAIPEI, May 22, 2026 /PRNewswire/ — Gene Solutions, an innovative global biotechnology company advancing AI-powered multi-omics solutions for cancer detection and precision oncology, participated in the 30th Taiwan Joint Cancer Conference (TJCC 2026), marking its first major oncology conference presence in Taiwan.

Authors:

Gene Solutions Genomics Pte Ltd
Publisher:PR Newswire
Publication date:22 May 2026
Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026
Gene Solutions divider
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
Gene Solutions divider

triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy

Key finding:

TAIPEI, April 14, 2026 /PRNewswire/ — At the prestigious Taiwan Association of Obstetrics and Gynecology (TAOG) 2026 Annual Meeting—the nation’s largest obstetrics and gynecology society established in 1961— Gene Solutions Taiwan officially introduced triSure, a revolutionary non-invasive prenatal screening technology.

Authors:

Gene Solutions Genomics Pte Ltd
Publisher:PR Newswire
Publication date:14 April 2026
Genomics & AI Blood Test Detects Cancer Before Symptoms Appear in India
Gene Solutions divider
Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for Precision Screening and Cancer Care in the U.S.
Gene Solutions divider

Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for Precision Screening and Cancer Care in the U.S.

Key finding:

IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ — Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader in validation platforms for Laboratory Developed Tests (LDTs), announced a strategic collaboration to advance U.S. verification and clinical validation of liquid biopsy assays designed for cancer detection, profiling, and monitoring.

Authors:

Gene Solutions Genomics Pte Ltd
Publisher:PR Newswire
Publication date:21 January 2026
Gene Solutions Concludes Successful ESMO Asia Congress 2025 with AI-Powered Multi-Omics Liquid Biopsy Symposium and Two Best Poster Awards
Gene Solutions divider

Gene Solutions Concludes Successful ESMO Asia Congress 2025 with AI-Powered Multi-Omics Liquid Biopsy Symposium and Two Best Poster Awards

Key finding:

SINGAPORE, Dec. 20, 2025 /PRNewswire/ — Gene Solutions, a pioneering genetic testing company, announced key achievements at the European Society for Medical Oncology (ESMO) Asia Congress 2025—held in Singapore on December 5–7. Highlights included a full-house symposium, seven scientific abstracts with two earning Best Poster designations, and meaningful engagement with thousands of oncologists from across the Asia-Pacific region at the company’s exhibition booth.

Authors:

Gene Solutions Genomics Pte Ltd
Publisher:PR Newswire
Publication date:20 December 2025
AI-Powered Multi-Cancer Early Detection Ushers in a New Era of Precision Medicine
Gene Solutions divider

SPOT-MAS Launches in Taiwan: AI-Powered Multi-Cancer Early Detection Ushers in a New Era of Precision Medicine

Key finding:

TAIPEI, Nov. 28, 2025 /PRNewswire/ — Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI). Multi-Cancer Early Detection (MCED) has become a global trend, and Taiwan joins this movement with the introduction of SPOT-MAS – an advanced screening solution developed by Gene Solutions, a global leader in precision oncology and genomics, in collaboration with local partner Gene Health.

Authors:

Gene Solutions Genomics Pte Ltd
Publisher:PR Newswire
Publication date:28 November 2025
APAC Precision Oncology Conference Outlines the Future of Early Detection and Personalized Treatment
Gene Solutions divider

AI and Multi-omics are Transforming Cancer Care: APAC Precision Oncology Conference Outlines the Future of Early Detection and Personalized Treatment

Key finding:

HONG KONG, Nov. 17, 2025 /PRNewswire/ — The APAC Precision Oncology Conference 2025, themed Artificial Intelligence (AI) & Multi-omics in Cancer Management, convened in Hong Kong on November 1, marking Lung Cancer Awareness Month with a clear message: AI and multi-omics are no longer theoretical – they are driving real-world advancements in cancer care across the Asia-Pacific (APAC) region.

Authors:

Gene Solutions Genomics Pte Ltd
Publisher:PR Newswire
Publication date:01 November 2025
Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials
Gene Solutions divider

Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials

Key finding:

Raffles Medical Group (the Group) and Gene Solutions have signed a Memorandum of Understanding (MOU) on 22 October 2025 to streamline patient recruitment for oncology clinical trials, marking a significant milestone in advancing precision medicine in Southeast Asia.

Authors:

Gene Solutions Genomics Pte Ltd
Publisher:PR Newswire
Publication date:27 October 2025
1
2
3
Discover More